Landscapes / Companies
Merz Therapeutics GmbH not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials
Trials
2 active
3 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Acetylcholine release Inhibitor; neuromuscular blocker |
Merz Pharmaceuticals |
Approved | Mar 2027Phase 3 trial completes | ||
| Next date | Mar 2027 · Phase 3 trial completes | ||||
| Also tested for | Episodic Migraine, Chronic Migraine | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021